ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 797

Clinical and Biomechanical Characteristics of Total Hip Arthroplasty Responders and Nonresponders

Genna Waldman1 and Kharma C. Foucher2, 1Rush Medical College, Chicago, IL, 2Orthopedic Surgery, Rush University Medical Center, Chicago, IL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Biomechanical testing, outcome measures and total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis

Session Type: Abstract Submissions (ARHP)

Background/Purpose: In a recent study, 14% of total hip arthroplasty (THA) patients were classified as nonresponders, using osteoarthritis (OA) treatment response criteria1.  Identifying characteristics of responders and nonresponders could lead to better ways to identify and manage likely nonresponders.  The purpose of this study was to test the hypothesis that responders have different preoperative and postoperative clinical and gait characteristics than nonresponders.  A secondary goal was to evaluate the utility of the Harris hip score (HHS) for calculating response.

Methods: We identified 132 THA patients with pre- and one year postoperative gait and HHS data from our IRB-approved data repository.  We calculated responder criteria in three ways based on the literature1: (i) Return to Normal (RTN): follow-up HHS ≥ 2 standard deviations above baseline; (ii) a modified version of OMERACT-OARSI responder criteria: relative change ≥ 20%; and (iii) Minimally Important Different (MID): follow-up HHS score ≥ 0.5 standard deviation above baseline. Gait variables of interest were self-selected normal walking speed, sagittal plane dynamic range of motion (ROM) and the 3D peak external moments. We used t-tests to compare pre- and postoperative gait variables for responders and nonresponders.

Results: 20%, 13% and 7% of patients were classified as nonresponders based on RTN, modified OMERACT-OARSI, and MID criteria, respectively. Using the modified OMERACT-OARSI criteria, baseline physical characteristics were similar for both groups (table).  Preoperatively, nonresponders had 35% higher HHS (p<0.001) and 25% higher ROM (p=0.021) compared to responders.  After surgery, nonresponders had significantly lower HHS compared to responders (p<0.001), as well as lower adduction and external rotation moments (p=0.038).  Findings were similar when comparisons were done using the other responder criteria.

Conclusion: Although a different score was used, a similar proportion of THA patients were classified as nonresponders here as in a previous study1.  This suggests that the HHS can be used to calculate response criteria if WOMAC scores are unavailable.  HHS and ROM were initially higher in patients who would become nonresponders, but after surgery the nonresponders were left with lower mean HHS and lower adduction and external rotation moments. These gait moments reflect net activity of hip abductors.  More work is needed to determine whether addressing the abductor impairment suggested by the biomechanical data would improve response. These results demonstrate that some patients who would appear to be more highly functioning before surgery may have both poorer responses and poorer final outcomes.

References: 1. Judge et al., Arthritis Care Res. 62:480-8, 2010.

Acknowledgement: Rush Research Mentoring Program Young Investigators Grant

 

 

Table.  Characteristics of THA subjects classified as responders and nonresponders

 

 

 

Responders (87%)

Nonresponders (13%)

p value

 

 

Baseline Physical Characteristics

Age (yrs)

60 ± 10

61 ± 10

0.868

BMI (kg/m2)

29 ± 5

28 ± 4

0.475

Sex

58 F/57 M

8 F/9 M

0.795

 

 

Clinical Characteristics

*Preoperative HHS

55 ± 13

74 ± 14

<0.001

*Postoperative HHS

93 ± 8

80 ± 17

<0.001

*Absolute Change

39 ± 12

6 ± 8

<0.001

*Relative Change (%)

80 ± 44

9 ± 11

<0.001

 

 

Preoperative Gait  Biomechanics

‘Normal’ walking speed (m/s)

1.01 ± 0.24

1.02 ± 0.20

0.930

*Dynamic sagittal plane range of motion (degrees)

16 ± 6

20 ± 6

0.021

Peak Flexion Moment (%Body Weight x Height)

4.19 ± 1.49

4.97 ± 1.98

0.140

Peak Extension Moment (%Body Weight x Height)

1.79 ±0.86

1.80 ± 0.67

0.954

Peak Adduction Moment (%Body Weight x Height)

3.45 ± 1.02

3.23 ± 1.30

0.423

Peak Abduction Moment (%Body Weight x Height)

1.60 ± 0.86

1.73 ± 0.75

0.548

Peak External Rotation Moment (%Body Weight x Height)

0.33 ± 0.21

0.34 ± 0.26

0.818

Peak Internal Rotation Moment (%Body Weight x Height)

0.37 ± 0.22

0.37 ± 0.15

0.994

 

 

Postoperative Gait Biomechanics

‘Normal’ walking speed (m/s)

1.19 ±0.19

1.13 ± 0.19

0.249

Dynamic sagittal plane hip range of motion (degrees)

25 ± 6

25 ± 6

0.915

Peak Flexion Moment (%Body Weight x Height)

5.91 ± 2.03

5.82 ± 2.17

0.852

Peak Extension Moment (%Body Weight x Height)

2.70 ± 1.10

2.82 ± 0.83

0.664

*Peak Adduction Moment (%Body Weight x Height)

3.54 ± 0.94

3.03 ± 0.91

0.038

Peak Abduction Moment (%Body Weight x Height)

1.88 ± 0.84

1.87 ± 0.97

0.921

*Peak External Rotation Moment (%Body Weight x Height)

0.43 ± 0.23

0.31 ± 0.21

0.038

Peak Internal Rotation Moment (%Body Weight x Height)

0.51 ±0.21

0.44 ±0.18

0.201

 

*bold text indicates t-test or chi-square test p<0.05

 


Disclosure:

G. Waldman,
None;

K. C. Foucher,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-and-biomechanical-characteristics-of-total-hip-arthroplasty-responders-and-nonresponders/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology